1 / 39

TUBERCULOSIS Diagnosis & treatment

TUBERCULOSIS Diagnosis & treatment. Dr. Fazli Wahab FCPS(Med), FCPS( Pulmonology ) Assisstant Prof Peshawar Medical College. Diagnostic Tools. Microscopy AFB smear Histology AFB Culture Radiology Tuberculin skin test Serological Tests. AFB smear. Rapid and inexpensive. Granuloma.

inigo
Download Presentation

TUBERCULOSIS Diagnosis & treatment

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. TUBERCULOSISDiagnosis & treatment Dr. FazliWahab FCPS(Med), FCPS(Pulmonology) Assisstant Prof Peshawar Medical College

  2. Diagnostic Tools • Microscopy • AFB smear • Histology • AFB Culture • Radiology • Tuberculin skin test • Serological Tests

  3. AFB smear Rapid and inexpensive

  4. Granuloma

  5. Mycobacterial Culture • Definitive diagnosis • Growth detected after 4–8 weeks.

  6. Radiographic Procedures The "classic" picture is that of upper-lobe disease with infiltrates and cavities,

  7. X-ray chest appearance can be any of the following • Infiltration • Cavitations • Fibrosis with traction • Enlargement of hilar and mediastinal lymph node • Pleural effusion/empyema • Nodular/ Miliary shadows

  8. Mantoux Tuberculin Test (MT)/ Tuberculin Skin Test (TST) Test TB infection in adults and children

  9. Serological Tests • Not routinely used • Polymerase Chain Reaction (PCR) • Interferon Gamma release assays (IGRS) • Enzyme Assays & Chromatographic assays: • Unreliable & Ineffective methods • No role in diagnosis in any form of TB • Mycodot assay • ICT TB

  10. Treatment

  11. Two aims • Interrupt transmission • Prevent morbidity and death.

  12. Anti-tuberculosis Drugs 1ST LINE DRUGS: • Isoniazid (H) • Rifampicin (R) • Pyrazinamide (Z) • Ethambutol (E) • Streptomycin (S)

  13. Regimens Standard short course regimens 6-8 months. An initial, intensive or bactericidal, phase and A continuation, or sterilizing, phase.

  14. DOTS DOTS(directly observed treatment, short-course), the WHO-recommended TB control strategy.

  15. New Cases • Sputum smear positive pulmonary TB • Sputum smear negative pulmonary TB • Extra-pulmonary tuberculosis • WHO Category I: • New SS +VE Pulmonary TB • Severe Extra-Pulmonary • Severe SS –VE Pulmonary TB • WHO Category III: • New SS-VE Pulmonary TB • Extra-Pulmonary (less severe) Initial Intensive Phase HRZE : 2 Months Continuation Phase HR: 4months OR HE: 6 Months

  16. RE-TREATMENT CASES/ WHOCategory II: • Relapse • Treatment Failures • Smear positive patients who have taken ATT for more than one month and defaulted INITIAL INTENSIVE PHASE (3months)HRZES: 2MONTHS Then HRZE:1 Month CONTINUATION PHASE HRE: 5 Months

  17. No Treatment is better than Poor Treatment • Drug-resistant TB is caused by: • Inconsistent or partial treatment, when patients do not take all their medicines regularly for the required period. • Doctors and health workers prescribe the wrong treatment regimens, or because • The drug supply is unreliable.

  18. The ultimate result is the multidrug-resistant TB (MDR-TB) or extensively-drug resistant TB (XDR-TB) In MDR-TB the Mycobacterium Tuberculosis is resistant to Rifampacin and INH with or without resistance to other 1st ATT. Treatment is difficult and expensive.

  19. Prevention • The best way to prevent tuberculosis is to Treat. • Additional strategies include • BCG vaccination and • Treatment of persons with latent tuberculosis infection who are at high risk of developing active disease.

  20. ATT in Special situations • Pregnancy • Infants of T.B. mothers & Breast Feeding • Women on O.C.P • Renal Impairment • ATT Induced Hepatitis • HIV - Infected or AIDS

  21. Pregnancy • H, R, Z, E : Safe • Streptomycin: Ototoxic • May cause deafness in babies • Contraindicated

  22. Infants of T.B. mothers & Breast Feeding • Mothers must continue A.T.T during feeding • Child should not be separated • Mother should cover her mouth during cough particularly if smear +ve • INH prophylaxis : 5 mg/Kg 2 months

  23. Infants of T.B. mothers & Breast Feeding • Do T.T: • If –ve • Stop INH, give BCG • If +ve • Continue INH 4 months • Then BCG • Do not give BCG while on INH • INH resistant BCG • Rifampicin + INH – 3 months

  24. Women on O.C.P • Rifampicin: • Hepatic enzyme inducer • O.C.P may become ineffective

  25. Renal Impairment • General principle: • Standard chemotherapy • Standard duration • Dose interval modification • Rifampicin and INH • Safe and use normal dose • Pyrazinamide • Needs dose interval adjustment

  26. Renal Impairment • Ethambutol • Nephrotoxic , Renal excretion - 80% unchanged • Ocular toxicity – dose dependent • Serum monitoring required • Amino glycosides – Streptomycin • Nephrotoxic, renal excretion- 80% unchanged • Needs dose interval adjustment in all stages • New recomandations • Avoid Aminoglycosides

  27. ATT Induced Hepatitis • Usually present early but may present any time • Mild / transient derangement in LFTs is normal (15 – 20 %) • TYPES: • Hepatocellular: • Cholestatic • Mixed

  28. ATT Induced HepatitisRISK FACTOR • Age >35 years • Female sex • Oriental race (EAST ASIAN) • Pre-existing liver disease • Extensive tuberculosis • High alcohol consumption • Malnutrition and hypo Albuminemia • Other hepatotoxic drugs • Slow Acetylator status • High dosage in relation to body weight

  29. Management • ↑ ALT/AST (< Twice normal) • Continue ATT • Check after 2 weeks • ↑ ALT/AST (>Twice normal) • Continue ATT • Check LFTs weekly for 2 weeks • Then every 2 weeks until normal

  30. Management • ↑ ALT/AST (>Thrice normal) + Symptoms • Anorexia, Nausea, Vomiting, Abdominal Pain , Jaundice • STOP ATT • ↑ ALT/AST (>5 time normal) OR ↑ Bilirubin • Even If Patient Asymptomatic • Stop ATT • If patient is smear –ve / Clinically stable • Wait until LFTs are normal • No need for alternate drugs • If patient is smear +ve / Clinically unstable • Start Ethambutol, Streptomycin and one of the reserve drugs until LFT‘s are normal • Continue safe drugs until LFTs are normal

  31. Management • When LFT’s are normal • Reintroduce ATT to detect offending drugs • Start with least hepatotoxic one by one • INH > RIF > PZA • If no reaction • Continue ATT • Stop alternate drugs • If reaction has developed • Stop offending drug • Continue remaining drugs • Ensure adequate regimen and duration

  32. HIV - Infected or AIDS • Standard regimen – usually good response • Drug reactions more common • Thiacetazone should be avoided • Prolonged treatment

  33. Thanks

More Related